The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Induction of neoantigen-specific immune responses by VB10.NEO in combination with atezolizumab in heavily pretreated patients with advanced solid tumors: Final analysis of the phase 1b VB N-02 trial.
 
Sebastian Ochsenreither
Honoraria - AstraZeneca; BMS; immunocore; Janssen Oncology; Merck Serono; MSD
Consulting or Advisory Role - Immatics; immunocore; Janssen-Cilag; MSD; Pfizer
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - Cyclin A1 as T-cell target
Travel, Accommodations, Expenses - Janssen Oncology; Merck Serono; Pfizer
Other Relationship - Ipsen
 
Georgia Anguera
Consulting or Advisory Role - Ipsen; Merck; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Bristol-Myers Squibb-Ono Pharmaceutical; Ipsen; Johnson & Johnson/Janssen; Merck; MSD Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb Spain; Ipsen; Johnson & Johnson/Janssen; Merck; MSD Oncology
 
Sebastian Dieter
No Relationships to Disclose
 
Nikolaos Trikalinos
Research Funding - Bristol-Myers Squibb (Inst); Elevar Therapeutics (Inst); Exelixis (Inst); Merck (Inst); Novartis (Inst); Nykode Therapeutics (Inst)
 
Siqing Fu
Research Funding - Abbisko (Inst); BeiGene (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); CUE Biopharma (Inst); Exelis (Inst); Exelis (Inst); Greenfire Bio (Inst); Hookipa Pharma (Inst); IMV (Inst); Innovent Biologics (Inst); K-Group Beta (Inst); Lilly (Inst); Lyvgen Biopharma (Inst); MacroGenics (Inst); MediLink Therapeutics (Inst); Millennium (Inst); Nerviano Medical Sciences (Inst); NeuPharma, Inc. (Inst); NextCure (Inst); NIH/NCI (Inst); Ningbo NewBay Medical Technology (Inst); Novartis (Inst); NovoCure (Inst); Nykode Therapeutics (Inst); Parexel International, LLC (Inst); Pionyr (Inst); PureTech (Inst); Sellas Life Sciences (Inst); Soricimed (Inst); SQZ Biotech (Inst); Sumitomo Dainippon Pharma Oncology (Inst); Taiho Oncology (Inst); Treadwell Therapeutics (Inst); Turnstone Bio (Inst); Tyligand Bioscience (Inst); Virogin Biotech (Inst)
 
Beatriz Castelo Fernández
No Relationships to Disclose
 
Aitana Calvo Ferrándiz
Consulting or Advisory Role - AstraZeneca Spain; BMSi; Lilly; Merck
Expert Testimony - Amgen; Pierre Fabre; SERVIER
Travel, Accommodations, Expenses - Lilly; Merck; Novartis; Pharmathen
 
So Yeon Kim
Consulting or Advisory Role - Amgen; Genentech; Revolution Medicines
Research Funding - AstraZeneca (Inst); Bioinvent (Inst); Boehringer Ingelheim (Inst); Bridgebio (Inst); Bristol Myers Squibb Foundation (Inst); DynamiCure Biotechnology (Inst); Genentech (Inst); Genmab (Inst); Gilead Sciences (Inst); Loxo/Lilly (Inst); Mirati Therapeutics (Inst); Monte Rosa Therapeutics (Inst); Seagen (Inst); Takeda (Inst); Vaccibody (Inst)
 
Laura Medina Rodriguez
Speakers' Bureau - Merck Sharp & Dohme; Novartis; SERVIER
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Novartis; SERVIER
 
Kaja Christine Graue Berg
Employment - Nykode Therapeutics
 
Hariz Iskandar Bin Hassan
Employment - BioNTech SE
Consulting or Advisory Role - Bambusa Therapeutics; Bicara Therapeutics; Duality Biologics; MediLink Therapeutics; Nykode Therapeutics; RiboX Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Anders Rosholm
Employment - Nykode Therapeutics A/S
Travel, Accommodations, Expenses - Nykode Therapeutics A/S
 
Agnete Fredriksen
Employment - Nykode Therapeutics
 
N-02 Investigators
No Relationships to Disclose